Nuvation Bio Inc. (NUVB) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Nuvation Bio Inc. (NUVB) Bundle
Explore the financial prospects of Nuvation Bio Inc. (NUVB) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to determine Nuvation Bio Inc. (NUVB) intrinsic value and inform your investment decisions.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -32.1 | -43.4 | -89.3 | -119.5 | -99.6 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Depreciation | .0 | .1 | .4 | .5 | .2 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
EBIT | -32.1 | -43.6 | -89.7 | -120.0 | -99.8 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Total Cash | 118.9 | 215.8 | 765.4 | 661.0 | 611.2 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | 1.1 | 3.0 | 2.5 | 3.7 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Inventories | .0 | 2.9 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | 2.0 | 2.2 | 3.9 | 2.1 | 2.2 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | -.7 | -.1 | -.3 | -.4 | -.1 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -32.1 | -41.3 | -82.4 | -102.1 | -99.8 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -30.7 | -45.2 | -79.5 | -103.2 | -100.8 | 1.5 | .0 | .0 | .0 | .0 |
WACC, % | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 | 10.82 |
PV UFCF | ||||||||||
SUM PV UFCF | 1.3 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | 1 | |||||||||
Net Debt | -39 | |||||||||
Equity Value | 40 | |||||||||
Diluted Shares Outstanding, MM | 219 | |||||||||
Equity Value Per Share | 0.18 |
What You Will Get
- Real Nuvation Bio Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Nuvation Bio’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive Data: Nuvation Bio Inc.'s (NUVB) historical financial reports and pre-filled projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Observe the recalculation of Nuvation Bio Inc.'s (NUVB) intrinsic value instantly.
- Intuitive Visualizations: Dashboard graphs showcase valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and financial professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based Nuvation Bio Inc. (NUVB) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other key metrics.
- Instant Calculations: The model automatically recalculates Nuvation Bio Inc.’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial decisions.
Why Choose Nuvation Bio Inc. (NUVB)?
- Innovative Solutions: Leverage cutting-edge technology for advanced biopharmaceutical development.
- Expert Team: Collaborate with industry leaders and experienced professionals in biotech.
- Robust Pipeline: Benefit from a diverse range of therapeutic candidates targeting unmet medical needs.
- Commitment to Quality: Adhere to the highest standards in research and development for reliable results.
- Growth Potential: Invest in a company poised for significant advancements in the biopharmaceutical landscape.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Nuvation Bio Inc. (NUVB) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Nuvation Bio Inc. (NUVB).
- Consultants: Deliver professional valuation insights on Nuvation Bio Inc. (NUVB) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Nuvation Bio Inc. (NUVB) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios, including Nuvation Bio Inc. (NUVB).
What the Template Contains
- Pre-Filled DCF Model: Nuvation Bio Inc.'s (NUVB) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Nuvation Bio Inc.'s (NUVB) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.